EXTON,
Pa., Oct. 10, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that it will release third-quarter financial results
before the market opens on Thursday, October
24, 2024, and will follow with a conference call to discuss
the results and business expectations at 9:00 a.m. Eastern Time.
The live webcast will be made available via the Company's
Investor Relations website click here.
To ask questions on the conference call, participants need to
register in advance by clicking here. Registered telephone
participants will receive the dial-in number along with a unique
PIN number that will enable them to ask questions on the
call.
A slide presentation will be made available on the day of the
call in the Investors section of the Company's website. A replay of
the conference call and webcast will be available on the Company's
website. Replay of the webcasts will be available for
approximately 90 days after the events.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With over
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or
its subsidiaries, in the United States and other
jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-to-host-third-quarter-2024-conference-call-302272228.html
SOURCE West Pharmaceutical Services, Inc.
